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Mesothelioma in Cyprus: a 
case series (1997-2007)
To the Editor: Mesothelioma is 
an uncommon primary malignancy 
that is highly aggressive and origi-
nates from mesothelial cells lining 
the pleural, peritoneal, and pericar-
dial cavities, with pleural mesotheli-
oma being the most common type.1 
The etiology and pathogenesis of 
malignant tumors have been exten-
sively studied and exposure to as-
bestos/asbestiform fibers, with the 
strongest association seen for am-
phibole asbestos fibers, is generally 
accepted to convey a higher risk for 
the development of mesothelioma. 
An association between occupa-
tional exposure to asbestos and me-
sothelioma was first established in 
1935.2 Besides asbestos, viral infec-
tion, and radiation have been sug-
gested as etiologic factors for meso-
thelioma. Genetic susceptibility and 
type of mineral fibers contribute to 
an increased risk. An epidemic in 
Cappadocia, Turkey, indicated that 
genetic background and exposure to 
an asbestiform mineral fiber, erion-
ite, had a significant contribution 
for the development of disease.3
The incidence of mesothelioma 
varies across different regions of 
the world and appears to be asso-
ciated with occupational and envi-
ronmental exposures. In Cyprus, 
an association between exposure to 
the asbestos fiber tremolite, which 
occurs naturally on the island, and 
the development of mesothelioma 
has long been suggested.4 However, 
data on the annual incidence of 
mesothelioma in Cyprus have only 
been reported anecdotally (personal 
communication). Our objective was 
to examine the incidence of meso-
thelioma in Cyprus and to analyze 
its basic characteristics through a 
case series investigation.
We identified the cases of meso-
thelioma which occurred in Cyprus 
during the past decade through 
the existing medical records of all 
cases treated by the Bank of Cyprus 
Oncology Center and the Nicosia 
General Hospital between 1997 
and 2007. A total of 59 cases of me-
sothelioma were identified over the 
past decade. Thirty-five were male 
(59%) and 24 (41%) were female 
patients. The average age of patients 
was 67 years, with ages ranging 
from 31 to 87 years. Most of the 
mesothelioma cases were identi-
fied in the right side of the thorax 
(26 cases, 44%) whereas 13 (22%) 
were found in the left side and the 
remaining had missing information 
on the side of the cancer location 
(20 cases). 
The majority of patients un-
derwent surgical treatment with 
pleurectomy (n=29, 49%). Four pa-
tients underwent pnemonectomy/
lobectomy, three patients received 
decortication and twelve patients 
had only a surgical procedure of 
pleural biopsy. Details of the surgi-
cal treatment for the remaining 11 
patients were not available. With 
respect to histological type, we 
identified 12 epithelioid tumors, 
12 adenoid, 6 sarcomatoid and 4 
mixed/other types of histology, 
whereas we did not have histol-
ogy information for the rest of the 
patients. Furthermore, 28 of the 
mesothelioma cases were found 
positive for the Carletinine bio-
marker. The incidence of mesothe-
lioma cases between 1997 and 2007 
ranged from 2.6 to 13.3 per million 
per year. Table 1 presents the num-
ber of cases and the incidence of 
mesothelioma in Cyprus by year of 
diagnosis. The incidence rates from 
2003-2007 were consistently higher 
than average, suggesting a possibly 
increasing trend.
To our knowledge, this is the 
first investigation of mesothelioma 
cases in Cyprus examining the in-
cidence and their basic characteris-
tics. Based on our data, during the 
study period (between 1997 and 
2007), the incidence of mesothe-
lioma cases in Cyprus fluctuated 
between 2.6 and 13.3 cases per one 
million population per year (mean 
incidence rate 7.1 per one million 
persons per year), while there was a 
suggestion of an increasing trend to-
wards the second half of the study. 
The distribution of mesothelioma 
cases during approximately the first 
half of the study period, from 1997 
to 2002, showed a yearly incidence 
rate ranging from 2.6 to 5.3 per mil-
lion. In contrast, during the second 
half of the study period (between 
2003 and 2007), the incidence rate 
of mesothelioma increased to about 
9.3 to 13.3 cases per million. This 
observation may suggest that there 
is an increasing trend in the inci-
dence of mesothelioma cases during 
the second half of the study period. 
However the available data are too 
limited to support such a hypoth-
esis. Nevertheless, our observation 
is consistent with other scientific re-
Table 1. Distribution of mesothelioma cases in Cyprus by year of 
diagnosis.
Year of diagnosis Number of cases Incidence ratea
1997 4 5.3
1998 3 4
1999 4 5.3
2000 2 2.6
2001 4 5.3
2002 2 2.6
2003 7 9.3
2004 7 9.3
2005 7 9.3
2006 10 13.3
2007 7 9.3
Missing 2 -
Average 59 7.1
aPer one million population
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ports suggesting an upcoming surge 
in the incidence of this disease dur-
ing the next decades.
In conclusion, our case series 
study provides data on the inci-
dence and basic characteristics of 
mesothelioma cases in Cyprus, 
which lies within the range of 
similar incidences reported in the 
region. Furthermore, our observa-
tion suggests an increasing trend 
of mesothelioma cases towards the 
second half of the study, possibly 
suggesting that a peak of the disease 
in Cyprus has not yet been realized. 
Our study supports the need for an 
active surveillance program of me-
sothelioma cases in Cyprus and the 
establishment of an active registry 
of former asbestos mine workers. 
This may be warranted given the 
relatively significant occupational 
exposure from asbestos mines in 
the past and the risks to former 
asbestos workers and the general 
population due to the extensive use 
of asbestos fibers in many building 
materials, which are likely to pres-
ent an important population hazard 
within the next decades.
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